Wikidata

(Q42710837)

English

Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,

scientific article published on 26 June 2013

In more languages

Statements

title
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23742252
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742252%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42710837&oldid=1801612083"